Molecular Genetics of Type 1 Glycogen Storage Disease
Overview
Authors
Affiliations
Glycogen storage disease type 1 (GSD 1) comprises a group of autosomal recessive inherited metabolic disorders caused by deficiency of the microsomal multicomponent glucose-6-phosphatase system. Of the two known transmembrane proteins of the system, malfunction of the catalytic subunit (G6Pase) characterizes GSD 1a. GSD 1 non-a is characterized by defective microsomal glucose-6-phosphate or pyrophosphate/phosphate transport due to mutations in G6PT (glucose-6-phosphate translocase gene) encoding a microsomal transporter protein. Mutations in G6Pase and G6PT account for approximately 80 and approximately 20% of GSD 1 cases, respectively. G6Pase and G6PT work in concert to maintain glucose homeostasis in gluconeogenic organs. Whereas G6Pase is exclusively expressed in gluconeogenic cells, G6PT is ubiquitously expressed and its deficiency generally causes a more severe phenotype. Rapid confirmation of clinically suspected diagnosis of GSD 1, reliable carrier testing, and prenatal diagnosis are facilitated by mutation analyses of the chromosome 11-bound G6PT gene as well as the chromosome 17-bound G6Pase gene.
Gul B, Firasat S, Shan T, Tehreem R, Afshan K PLoS One. 2023; 18(11):e0288965.
PMID: 38033126 PMC: 10688888. DOI: 10.1371/journal.pone.0288965.
Li S, Saviano A, Erstad D, Hoshida Y, Fuchs B, Baumert T J Clin Med. 2020; 9(12).
PMID: 33255794 PMC: 7760293. DOI: 10.3390/jcm9123817.
Molecular diagnosis of glycogen storage disease type I: a review.
Beyzaei Z, Geramizadeh B EXCLI J. 2019; 18:30-46.
PMID: 30956637 PMC: 6449677.
Update in global trends and aetiology of hepatocellular carcinoma.
Rawla P, Sunkara T, Muralidharan P, Raj J Contemp Oncol (Pozn). 2018; 22(3):141-150.
PMID: 30455585 PMC: 6238087. DOI: 10.5114/wo.2018.78941.
Dale D, Bolyard A, Marrero T, Kelley M, Makaryan V, Tran E Curr Opin Hematol. 2018; 26(1):16-21.
PMID: 30451720 PMC: 7000169. DOI: 10.1097/MOH.0000000000000474.